Antibiotic Shortage 2025. Although the number of antibacterial agents in the clinical pipeline increased from 80 in 2021 to 97 in 2023, there is a pressing need for new, innovative agents for serious. Pfizer has reported manufacturing delays for.
Improving access to antibiotics will prevent more than 50 million deaths by 2050. Ema’s executive steering group on shortages and safety of medicinal products (mssg) met recently to discuss the progress made and to agree on the next steps in the coordinated response to the ongoing shortages.